May 26, 2011 – Cinterion, a cellular machine-to-machine (M2M) communication modules company, and TZ Medical, a manufacturer of critical-care medical products, announced Aera-CT, a lightweight and cost effective mHealth heart arrhythmia monitoring device (a Holter monitor). Equipped with the Cinterion MC75i module, the Aera-CT is expected to be commercially available in North America in Q3, 2011, followed by rolling launches throughout the world.

May 26, 2011 - Carestream Health’s Vue Motion zero-footprint, Web-based enterprise viewer enables convenient on-demand access to imaging data and patient information by clinicians anytime, anywhere. This viewer’s support of mobile devices such as Apple iPads and tablet PCs is pending U.S. Food and Drug Administration (FDA) market clearance, but is available in other countries worldwide.

May 25, 2011 – Boston Scientific Corp. today announced it received approval from the U.S. Food and Drug Administration (FDA) to market its 2.25 mm Promus everolimus-eluting coronary stent system for use in vessels as small as 2.25 mm in diameter. The company plans to immediately launch the product in the United States.

The U.S. Food and Drug Administration (FDA) cleared the Xience nano everolimus-eluting coronary stent system for the treatment of coronary artery disease in small vessels. The Xience nano, which is based on the same platform as the Xience V everolimus-eluting coronary stent, offers physicians in the United States a new option for treating patients with coronary artery disease in vessels as small as 2.25 mm in diameter.

May 24, 2011 - Cordis announced it has obtained CE mark for its Empira and Empira NC RX percutaneous transluminal coronary angioplasty (PTCA) dilatation catheters for the treatment of coronary artery disease. The Empira systems are designed to enable interventional cardiologists to open patients' narrowed coronary arteries during angioplasty and stenting procedures. The company also highlighted its radial access products at EuroPCR 2011.

Subscribe Now